Maravai Lifesciences Holdings (MRVI) Share-based Compensation (2020 - 2026)

Maravai Lifesciences Holdings' Share-based Compensation history runs 7 years deep, the most recent figure standing at $6.7 million for Q1 2026.

• In Q1 2026, Share-based Compensation fell 35.18% year-over-year to $6.7 million; the TTM figure through Mar 2026 stood at $26.5 million (down 44.49% YoY), while the FY2025 annual figure was $30.2 million, down 38.94% from the prior year.
• Share-based Compensation was $6.7 million for Q1 2026 at Maravai Lifesciences Holdings, up from $3.9 million in the prior quarter.
• In the past five years, Share-based Compensation ranged from a high of $13.8 million in Q2 2024 to a low of $3.6 million in Q1 2022.
• Historically, Share-based Compensation has averaged $8.2 million across 5 years, with a median of $9.1 million in 2025.
• The sharpest annual moves came in 2022 and 2025: Share-based Compensation jumped 168.83% in 2022, then sank 62.77% in 2025.
• A 5-year view of Share-based Compensation shows it stood at $6.0 million in 2022, then surged by 55.83% to $9.3 million in 2023, then advanced by 12.88% to $10.5 million in 2024, then sank by 62.77% to $3.9 million in 2025, then soared by 71.75% to $6.7 million in 2026.
• The last three Share-based Compensation figures came in at $6.7 million (Q1 2026), $3.9 million (Q4 2025), and $9.1 million (Q3 2025), per Business Quant data.